27Apr
[Video] Six Things You Need to Know About Life Sciences M&A During and After COVID-19
While life sciences M&A activity soared to a new high in 2019, the uncertainty surrounding the pandemic has led to a slow down in deal making activity. However, as the crisis in the U.S. subsides and the U.S. economy stabilizes, we expect life...
By:
Arnall Golden Gregory LLP
Related
Over the past several years, regulators and market participants increasingly have called for the exp...
Read More >
Courts and arbitral tribunals in many jurisdictions have the power to order contractors to perform b...
Read More >
Below is a current status report on a number of key items, including several changes since our April...
Read More >
Maintaining records to meet the burden of proof and demonstrate causation in your construction claim...
Read More >
New York recently extended its protections of the New York City Human Rights Law to non-employees, i...
Read More >
Today, the U.S. Department of Labor (“DOL”) announced its Final Rule updating the salary threshold...
Read More >